The Effect of Music Therapy as an Adjuvant in the Vital Signs of the Neonate
- Disease/Condition
- Neonatal Disease
- Drug/Device/Intervention
- Music therapy
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Claudia Aristizábal
- Funder
- Sanitas University
- Location
- Bogotá, Colombia
- Phase
- N/A
- Start date
- May 03, 2024
- End date
- Jun 30, 2024
- Enrollment
- 45 participants
Heart rate
The admission of a newborn to the neonatal intensive care unit (NICU) represents a
 potentially harmful sound environment coupled with multiple stressful events. However, a
 strategy such as music therapy (delivered by a trained music therapist) appears to be a
 non-invasive, safe, and cost-effective alternative that assists newborns in their
 physiological self-regulation with a beneficial effect on stabilizing neonatal vital signs,
 so it can be used as a complementary strategy to medical management. The aim of this study is
 to determine the effect of live and pre-recorded music therapy on vital sign variables in
 newborns older than 32 weeks hospitalized in the neonatal intensive care unit of a
 high-complexity health institution in Colombia.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06408064
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06408064 through Pure Global AI's free database. This phase not specified trial is sponsored by Claudia Aristizábal and is currently Not yet recruiting. The study focuses on Neonatal Disease. Target enrollment is 45 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.